Body mass index and blood glucose: Correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH)

Rheumatology International

Volumn 26, Issue 4, 2006, Pages 292-297

  Denko, Charles W ^a   Malemud, Charles J ^a,b,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; DISH; Growth hormone; Insulin; Insulin like growth factor 1

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPEROSTOSIS; INSULIN BLOOD LEVEL; MALE; OBESITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGE FACTORS; BLOOD GLUCOSE; BODY MASS INDEX; HUMAN GROWTH HORMONE; HUMANS; HYPERGLYCEMIA; HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL; INSULIN; INSULIN-LIKE GROWTH FACTOR I; OBESITY;

EID: 30744433105     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0588-8     Document Type: Article

References (33)

1. Bideci A, Cinaz P, Hasanoglu A, Elberg S (1997) Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in obese children. J Pediatr Endocrinol Metab 10:295-299
2. Argente J, Caballo N, Barrios V, Pozo J, Munoz MT, Chowen JA, Hernandez M (1997) Multiple endocrine abnormalities of growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab 82:2076-2083
3. Saitoh H, Kamoda T, Nakahara S, Hirano T, Nakamura N (1998) Serum concentrations of insulin, insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-3 is suppressed in normoinsulinaemic obese children. Clin Endocrinol (Oxford) 48:487-492
4. Park MJ, Kim HS, Kang JH, Kim DH, Chung CY (1999) Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children. J Pediatr Endocrinol Metab 12:139-144
5. Murray RD, Adams JE, Shalet SM (2004) Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab 89:1586-1591
6. Russell-Jones DI, Weissberger AJ (1996) The role of growth hormone in the regulation of body composition in the adult. Growth Regul 6:247-252
7. Shadid S, Jensen MD (2003) Effects of growth hormone administration in human obesity. Obes Res 11:170-175
8. Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA (1984) Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Eng J Med 311:1403-1407
9. Cambien F (1987) Is insulin the key factor to explain the association between body mass, blood pressure and glucose? Diabetes Metab 13:365-368
10. Moller LF, Jespersen J (1995) Elevated insulin levels in men: an 11-year follow-up study. J Cardiovasc Risk 2:339-343
11. Frystyk J, Vestbo E, Skjaerbaek C, Morgensen CE, Orskov H (1995) Free insulin-like growth factors in obesity. Metabolism 44:37-44
12. Strohl KP, Novak RD, Singer W, Cahan C, Boehm KD, Denko CW, Hoffstem VS (1994) Insulin levels, blood pressure and sleep apnea. Sleep 17:614-618
13. Abbasi F, Carantoni M, McLaughlin T, Reaven GM (2000) Plasma insulin concentration is more tightly linked to plasma leptin concentration than is body mass index. Metabolism 49:544-547
14. Resnick D, Shaul SR, Robin JM (1975) Diffuse idiopathic skeletal hyperostosis (DISH): Forestier's disease with extraspinal manifestations. Radiology 115:513-524
15. Utsinger PD, Resnick D, Shapiro R (1976) Diffuse skeletal abnormalities in Forestier's disease. Arch Int Med 136:763-768
16. Denko CW, Boja B, Moskowitz RW (1994) Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis - insulin, insulin-like growth factor-I, growth hormone. J Rheumatol 21:1725-1730
17. Littlejohn GO, Smythe HA (1984) Marked hyperinsulinemia after glucose challenge in patients with diffuse idiopathic skeletal hyperostosis. J Rheumatol 8:965-968
18. Denko CW, Boja B, Moskowitz RW (1996) Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders. Osteoarthr Cartilage 4:245-249
19. Denko CW, Malemud CJ (2002) Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Front Biosci 7:a37-a43
20. Moskowitz RW, Holderbaum D (2001) Clinical and laboratory findings in osteoarthritis. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions (14th Edition). Lea & Febiger, Philadelphia
21. National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 6(Suppl 2):51S-209S
22. Bray GA (1998) In defense of a body mass index of 25 as the cutoff point for defining overweight. Obes Res 6:461-462
23. Denko CW, Malemud CJ (1999) Metabolic disturbances and synovial fluid responses in osteoarthritis. Front Biosci 4:d686-d693
24. Denko CW, Boja B, Malemud CJ (2003) Intra-erythrocyte deposition of growth hormone in rheumatic diseases. Rheumatol Int 23:11-14
25. Vezyroglou G, Mitropoulos A, Antoniadis C (1996) A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study. J Rheumatol 23:672-676
26. Kiss C, Szilagyi M, Paksy A, Poor G (2002) Risk factors for diffuse idiopathic skeletal hyperostosis: a case-controlled study. Rheumatology (Oxford) 41:27-30
27. Sarzi-Puttini P, Atzeni F (2004) New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis). Curr Opin Rheumatol 16:287-292
28. Woo J, Ho SC, Yu AL, Sham A (2002) Is waist circumference a useful measure of predicting health outcomes in the elderly? Int J Obes Related Metab Disord 26:1349-1355
29. Chan DC, Watts GF, Barrett PH, Burke V (2003) Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM 96:441-447
30. Deurenberg P, Yap M (1999) The assessment of obesity: methods for measuring body fat and global prevalence of obesity. Baillieres Best Pract Res Clin Endocrinol Metab 13:1-11
31. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R (2002) Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 75:683-688
32. Janssen I, Katzmarzyk PT, Ross R (2004) Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79:379-384
33. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC (2001) Diet, lifestyle and the risk of diabetes mellitus in women. N Eng J Med 345:790-797